16
General Information
DRACP ID DRACP04813
Peptide Name 16
Sequence YRXG
Sequence Length 4
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic
Disulfide/Other Bond Native peptide
N-terminal Modification Free
C-terminal Modification Free
Other Modification X=Cα -dialkylated glycine (Aaa2,2 )
Chiral L
Physicochemical Information
Formula C17H24N6O4
Absent amino acids ACDEFHIKLMNPQSTVW
Common amino acids GRYX
Mass 54010
Pl 9.35
Basic residues 1
Acidic residues 0
Hydrophobic residues 0
Net charge 1
Boman Index -1412
Hydrophobicity -155
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 1490
Absorbance 280nm 496.67
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 16722632
Title Not available
Doi Not available
Year Not available
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
CancerPPD ID 3942
CancerPPD ID 3943
CancerPPD ID 3944
CancerPPD ID 3945
CancerPPD ID 3946
CancerPPD ID 3947
CancerPPD ID 3948
CancerPPD ID 3949
CancerPPD ID 3950
CancerPPD ID 3951
CancerPPD ID 3952
CancerPPD ID 3953
CancerPPD ID 3954
CancerPPD ID 3955
CancerPPD ID 3956
CancerPPD ID 3957
CancerPPD ID 3958
CancerPPD ID 3959
CancerPPD ID 3960
CancerPPD ID 3961
CancerPPD ID 3962
CancerPPD ID 3963
CancerPPD ID 3964
CancerPPD ID 3965